Results

CBOE Holdings Inc.

04/15/2019 | Press release | Distributed by Public on 04/15/2019 05:37

FibroGen Receives Orphan Drug Designation from the US FDA For Pamrevlumab for the Treatment of Duchenne Muscular Dystrophy



FibroGen Receives Orphan Drug Designation from the US FDA For Pamrevlumab for the Treatment of Duchenne Muscular Dystrophy

Benzinga Newsdesk      4/15/2019 6:03:42 AM